Predicting pathological response after radio-chemotherapy for rectal cancer: Impact of late oxaliplatin administration

Background and purpose null A previously introduced index based on early tumor (GTV) regression (ERITCP) during neo-adjuvant radio-chemotherapy of rectal cancer was used to investigate the impact of changes of oxaliplatin (OXA) delivery on the prediction of pathological complete response (pCR) and residual vital cell (RVC) fraction. null null null Materials and methods null Ninety-five patients were treated following an adaptive protocol...